1800 202 8726
Biopsy during treatment

Biopsy During Cancer Treatment — Safety, Timing, and What Changes in the Result

Many patients assume a biopsy cannot happen while they are on treatment. In most cases it can — but what your team must check first, and how the pathologist reads the result, is different from a biopsy taken before treatment begins.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Usually possible — Active treatment is not a reason to refuse a biopsy in most situations.
  • Blood counts matter — Your team checks platelets and clotting before proceeding, not after.
  • The result looks different — Chemotherapy and radiation both change how tissue appears under the microscope.
  • Timing can be adjusted — When not urgent, your team may plan around the safest point in your cycle.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A biopsy is usually possible during cancer treatment. What changes is the preparation — your team checks your blood counts and clotting before agreeing to proceed — and how the pathologist reads the result. Treatment-induced changes in tissue can look like tumour or mask it, so your pathologist must know what you are receiving and when.

How does chemotherapy affect biopsy differently from radiation?

ChemotherapyRadiation
Effect on tumour tissueCan cause cell death and inflammation that looks similar to active tumour under the microscopeCauses fibrosis and vascular changes that can persist for months after treatment ends
Effect on blood countsOften lowers platelets and white cells — risk is highest around the nadir, the low point of the cycleMainly affects counts when a large bone-marrow area is in the treatment field
Best timing for biopsyDuring a break between cycles, away from the nadirAfter the acute tissue reaction has settled — your team will judge the window
When your team proceeds regardlessAny new lesion needing urgent diagnosis, or a clinical change that cannot waitAny new or rapidly changing lesion where delay would affect management

What your team checks before agreeing to a biopsy during treatment

  • Blood counts, particularly platelets, are at a safe level for the procedure
  • Clotting is adequate, and any blood thinners are paused where clinically possible
  • The site is accessible and the approach carries acceptable risk at this point in your treatment
  • Imaging guidance can be arranged without unnecessary additional radiation exposure
  • The pathologist has been told exactly which treatments you are on and the date of your last dose
  • There is a clear clinical reason why waiting until treatment ends is not the right option

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Does being on treatment change what the pathologist sees?

Yes, and this is the part least understood by patients. Both chemotherapy and radiation alter the appearance of cells under the microscope — sometimes dramatically.

Treatment-induced changes can resemble active tumour. Active tumour can sometimes be mistaken for treatment effect. Your pathologist accounts for this when they have your full treatment history — but only then.

If a biopsy is taken during treatment, the request to the laboratory must include your drug regimen and the date of your last dose. A result read without that context may be misinterpreted.

Is there a better time in the cycle to have the biopsy?

For chemotherapy, the lowest-risk window is generally during a break between cycles, away from the nadir. Your team knows your schedule and will plan around it when the clinical situation allows.

After radiation, tissue reactions take time to settle. How long depends on the area treated and the dose received — your radiation oncologist will advise when the tissue is ready.

When the reason is urgent — a rapidly growing mass, a new lesion, or a clinical change that cannot wait — timing is adapted around that need. Urgency takes precedence over the ideal window.

Questions that come up most often

My doctor wants to biopsy while I am still on chemotherapy. Is that usual?

Yes, and often the right decision. A new or changing lesion during treatment needs to be characterised promptly — waiting until the end of treatment can delay a significant change in your management. The procedure is adapted: blood counts are checked, timing is planned around the cycle where possible, and the pathologist receives your full treatment history before reading the result. The fact that it is being done during treatment is careful planning, not a shortcut.

A new lesion has appeared during my treatment. Does it need to be biopsied?

Almost always yes, and promptly. A new lesion during treatment can mean progression of the original cancer, a second cancer, an infection, or a treatment-related change. Imaging alone usually cannot distinguish between these reliably. A biopsy gives your team the tissue answer they need to decide whether to continue, change, or stop your current treatment. Waiting risks acting on an assumption that may be wrong.

Can treatment make the biopsy result look better or worse than the reality?

It can complicate the interpretation, which is why your treatment history must accompany the sample. Chemotherapy can cause changes that look like tumour regression even when active cells remain. Radiation causes structural changes that persist long after treatment ends. These are known effects that experienced oncology pathologists account for when they have the context. The result is still meaningful — it requires more careful reading, not a less reliable one.

I am pregnant. Can I still have a biopsy?

A biopsy is generally possible during pregnancy, but the approach needs careful adaptation. Imaging guidance that uses ionising radiation — CT, fluoroscopy — is minimised or replaced with ultrasound wherever possible. Some sedation options are not safe in pregnancy; local anaesthesia is generally appropriate. Your team will involve an obstetrician in planning the procedure. Tell your team immediately if there is any chance you could be pregnant, so the approach is adapted before anything goes ahead.

My blood counts are very low right now. Will they wait?

If counts are below the level the team considers safe, they will usually wait for recovery — which can happen within days in some cases. If waiting is not possible because the clinical question is urgent, your team may take steps to support your counts first, or choose a less invasive approach. The threshold is a clinical decision based on the biopsy site, the technique, and your individual risk — not a fixed rule applied the same way for everyone.

Will radiation to an area permanently change what a biopsy from that area shows?

The changes can last months to years. Radiation-induced fibrosis, vascular damage, and cellular changes are long-lasting in the treated field. A biopsy from within a previously irradiated area must be interpreted with the radiation history included — the site, the date, and the dose are all relevant. If your biopsy report does not mention that the area was previously irradiated, raise this with your oncologist before accepting the interpretation.

Explore 102 more Your Result, What Comes Next and Support topics

HUB — Who Can Have a Biopsy? Special Situations

HUB — Your Biopsy Confirmed Cancer

All Your Result, What Comes Next and Support →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is a biopsy during chemotherapy more dangerous than one taken before treatment?

The main added risks are bleeding and infection, because chemotherapy often lowers platelets and reduces the immune response. These are manageable when blood counts are checked before the procedure and timing is planned away from the nadir. The overall risk depends on your counts at that point, the biopsy site, and the approach. Your team will not proceed if the risk is judged too high at that moment.

Will the biopsy result be less reliable because I am on treatment?

Not necessarily less reliable, but it requires more careful interpretation. A pathologist who has your full treatment history can account for treatment-induced changes and still give a meaningful result. The result becomes unreliable only when the treatment history is not provided to the laboratory, or when the sample is read without oncology pathology experience. Always confirm your drug regimen and last dose date were included in the request.

What is the nadir, and why does it affect when a biopsy is safe?

The nadir is the point in your chemotherapy cycle when blood counts are at their lowest — typically some days after a dose, though the timing varies by drug. Platelets affect how well blood clots after a needle procedure; white cells affect infection risk. Biopsying near the nadir means both risks peak together. Scheduling away from it reduces procedural risk when the clinical situation allows for that flexibility.

Can I continue my treatment on the same day as the biopsy?

That depends on the drug, the biopsy site, and the procedure. Blood thinners — including some targeted therapies — are often paused briefly around any procedure. Your oncologist and the interventional team will coordinate this, but raise it explicitly if a dose is scheduled close to your biopsy date. Do not pause any treatment on your own without asking your team first.

Who decides whether the timing is right — my oncologist or the doctor doing the biopsy?

Both, jointly. Your oncologist knows your treatment schedule, your blood count trajectory, and the urgency of the clinical question. The interventional radiologist or surgeon knows what is technically safe given the site and approach. The decision to proceed is made together. If you are not clear on why a particular timing has been chosen, ask for it to be explained before you give consent.

Do I need to give consent again for a biopsy done during treatment?

Yes. A biopsy during treatment is a separate procedure with its own consent, even if you consented to a biopsy before starting treatment. The risks specific to your current situation — including your blood counts at the time — should be explained before you sign. Consent is a conversation, not a formality. If anything is unclear, ask before the procedure goes ahead.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation